Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 2:37 am
Author: Getaka|Social: XLinkedIn

Arvee Laboratories (India) Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹120.48Overvalued by 16.33%vs CMP ₹144.00

P/E (76.3) × ROE (6.8%) × BV (₹28.50) × DY (2.00%)

₹48.57Overvalued by 66.27%vs CMP ₹144.00
MoS: -196.5% (Negative)Confidence: 68/100 (Moderate)Models: All 9: Overvalued
ModelCategoryValueWeightSignal
PE-ROEEarnings₹115.4222%Over (-19.8%)
Graham NumberEarnings₹34.7216%Over (-75.9%)
Earnings PowerEarnings₹16.3911%Over (-88.6%)
DCFCash Flow₹17.9713%Over (-87.5%)
Net Asset ValueAssets₹28.477%Over (-80.2%)
EV/EBITDAEnterprise₹42.189%Over (-70.7%)
Earnings YieldEarnings₹18.807%Over (-86.9%)
ROCE CapitalReturns₹45.419%Over (-68.5%)
Revenue MultipleRevenue₹34.865%Over (-75.8%)
Consensus (9 models)₹48.57100%Overvalued
Key Drivers: Wide model spread (₹16–₹115) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -4.2%

*Investments are subject to market risks

Investment Snapshot

41
Arvee Laboratories (India) Ltd scores 41/100 (Weak)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health61/100 · Moderate
ROCE 9.6% AverageROE 6.8% AverageD/E 0.41 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
Promoter holding at 73.5% Stable
Earnings Quality40/100 · Moderate
OPM contracting (13% → 10%) Declining
Quarterly Momentum15/100 · Weak
Revenue (4Q): -29% YoY DecliningProfit (4Q): -82% YoY DecliningOPM: 3.5% (down 8.5% YoY) Margin pressure
Industry Rank30/100 · Weak
P/E 76.3 vs industry 64.9 In-lineROCE 9.6% vs industry 13.0% AverageROE 6.8% vs industry 25.4% Below peers3Y sales CAGR: -2% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 2:37 am

Market Cap 159 Cr.
Current Price 144
Intrinsic Value₹48.57
High / Low 291/129
Stock P/E76.3
Book Value 28.5
Dividend Yield0.00 %
ROCE9.58 %
ROE6.79 %
Face Value 10.0
PEG Ratio-18.16

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Arvee Laboratories (India) Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Arvee Laboratories (India) Ltd 159 Cr. 144 291/12976.3 28.50.00 %9.58 %6.79 % 10.0
Chembond Chemicals Ltd 164 Cr. 122 490/10512.0 1211.43 %11.5 %10.5 % 5.00
Dai Ichi Karkaria Ltd 185 Cr. 248 472/21933.2 2491.41 %4.29 %4.20 % 10.0
Bhatia Colour Chem Ltd 198 Cr. 140 430/14040.8 73.10.00 %7.73 %5.17 % 10.0
HP Adhesives Ltd 269 Cr. 29.3 57.6/26.319.4 20.51.36 %13.6 %9.82 % 2.00
Industry Average12,530.04 Cr712.4964.87182.870.55%12.98%25.40%6.41

All Competitor Stocks of Arvee Laboratories (India) Ltd

Quarterly Result

MetricSep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales 22.7416.2512.567.608.917.706.1410.6012.538.916.457.483.45
Expenses 19.4814.5111.406.628.227.175.359.0611.038.576.237.143.33
Operating Profit 3.261.741.160.980.690.530.791.541.500.340.220.340.12
OPM % 14.34%10.71%9.24%12.89%7.74%6.88%12.87%14.53%11.97%3.82%3.41%4.55%3.48%
Other Income 0.060.070.060.090.090.190.210.110.160.190.210.170.23
Interest 0.110.090.070.070.080.050.050.080.050.050.070.040.04
Depreciation 0.480.490.480.350.420.350.370.310.300.280.270.290.30
Profit before tax 2.731.230.670.650.280.320.581.261.310.200.090.180.01
Tax % 25.27%25.20%100.00%24.62%25.00%25.00%81.03%25.40%25.19%25.00%22.22%5.56%0.00%
Net Profit 2.050.920.010.490.210.240.120.940.980.150.070.170.01
EPS in Rs 1.860.830.010.440.190.220.110.850.890.140.060.150.01

Last Updated: January 2, 2026, 11:00 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 23, 2026, 10:14 am

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 26.8234.4447.7854.9045.4247.3840.3361.3530.3538.4927.16
Expenses 21.8328.5440.6148.7339.4041.3134.6554.0627.4134.8824.85
Operating Profit 4.995.907.176.176.026.075.687.292.943.612.31
OPM % 18.61%17.13%15.01%11.24%13.25%12.81%14.08%11.88%9.69%9.38%8.51%
Other Income 0.100.510.230.350.350.560.461.350.640.660.75
Interest 3.073.483.331.630.990.580.370.390.250.250.22
Depreciation 1.492.072.152.352.292.412.322.081.501.151.16
Profit before tax 0.530.861.922.543.093.643.456.171.832.871.68
Tax % 66.04%-81.40%43.23%11.02%25.89%26.37%25.51%33.23%42.62%25.09%
Net Profit 0.191.551.092.262.302.682.574.121.052.152.08
EPS in Rs 0.231.910.992.052.092.432.333.740.951.951.88
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)715.79%-29.68%107.34%1.77%16.52%-4.10%60.31%-74.51%104.76%
Change in YoY Net Profit Growth (%)0.00%-745.47%137.02%-105.57%14.75%-20.63%64.42%-134.83%179.28%

Arvee Laboratories (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:-3%
3 Years:-2%
TTM:6%
Compounded Profit Growth
10 Years:%
5 Years:0%
3 Years:-5%
TTM:-9%
Stock Price CAGR
10 Years:%
5 Years:35%
3 Years:22%
1 Year:-12%
Return on Equity
10 Years:%
5 Years:10%
3 Years:9%
Last Year:7%

Last Updated: September 4, 2025, 11:40 pm

Balance Sheet

Last Updated: April 8, 2026, 2:30 am

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 4.054.055.515.515.5111.0211.0211.0211.0211.0211.02
Reserves -1.410.158.6910.9513.2510.4212.9217.0418.0920.2420.42
Borrowings 25.3224.9916.1512.873.878.883.131.001.001.031.03
Other Liabilities 7.256.4913.777.8111.0010.7311.619.638.455.298.11
Total Liabilities 35.2135.6844.1237.1433.6341.0538.6838.6938.5637.5840.58
Fixed Assets 13.1516.8814.8812.6513.1813.8113.8412.6812.6715.2715.25
CWIP 4.300.001.182.321.780.970.981.532.620.730.81
Investments 0.000.000.001.953.092.030.000.000.000.000.00
Other Assets 17.7618.8028.0620.2215.5824.2423.8624.4823.2721.5824.52
Total Assets 35.2135.6844.1237.1433.6341.0538.6838.6938.5637.5840.58

Reserves and Borrowings Chart

Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 4.036.029.4610.311.710.682.933.66-0.21
Cash from Investing Activity + -1.40-1.23-2.85-3.08-0.600.06-1.26-2.16-1.32
Cash from Financing Activity + -2.92-3.78-4.92-9.904.52-6.06-2.42-0.19-0.12
Net Cash Flow -0.291.001.68-2.675.63-5.32-0.751.31-1.64
Free Cash Flow 2.544.687.968.02-0.53-1.681.471.07-2.06
CFO/OP 57%96%158%184%44%29%64%139%10%

Free Cash Flow

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-20.33-19.09-8.98-6.702.15-2.812.556.291.942.58

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 82.6187.12118.2552.6652.4060.70109.7872.9473.4879.66
Inventory Days 155.08104.5399.6142.9080.9691.9693.2442.29159.0280.31
Days Payable 130.7398.14150.0355.84125.63118.08160.1273.30164.4957.72
Cash Conversion Cycle 106.9693.5067.8439.727.7234.5942.9041.9468.01102.25
Working Capital Days 30.0830.8430.79-6.5210.29-10.6349.9670.4495.97106.59
ROCE %15.19%17.64%13.67%14.90%14.92%12.89%23.34%6.83%10.00%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 73.50%73.50%73.50%73.50%73.50%73.50%73.50%73.50%73.50%73.50%73.50%73.50%
Public 26.50%26.50%26.50%26.50%26.50%26.50%26.50%26.50%26.50%26.50%26.50%26.50%
No. of Shareholders 8648939051,3721,2981,4801,4161,6231,5761,5051,5051,861

Shareholding Pattern Chart

No. of Shareholders

Arvee Laboratories (India) Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 1.950.953.742.342.43
Diluted EPS (Rs.) 1.950.953.742.342.43
Cash EPS (Rs.) 2.992.315.634.444.61
Book Value[Excl.RevalReserv]/Share (Rs.) 28.3726.4225.4621.7319.45
Book Value[Incl.RevalReserv]/Share (Rs.) 28.3726.4225.4621.7319.45
Revenue From Operations / Share (Rs.) 34.9227.5455.6736.5942.99
PBDIT / Share (Rs.) 3.873.257.835.566.01
PBIT / Share (Rs.) 2.831.895.953.463.83
PBT / Share (Rs.) 2.611.665.593.133.30
Net Profit / Share (Rs.) 1.950.953.742.342.43
PBDIT Margin (%) 11.0811.7814.0715.1913.98
PBIT Margin (%) 8.106.8510.689.448.90
PBT Margin (%) 7.456.0210.048.557.68
Net Profit Margin (%) 5.573.466.716.385.65
Return on Networth / Equity (%) 6.863.6114.6710.7512.48
Return on Capital Employeed (%) 9.246.6521.9515.1418.53
Return On Assets (%) 5.712.7510.646.656.52
Long Term Debt / Equity (X) 0.030.030.030.040.04
Total Debt / Equity (X) 0.030.030.030.130.41
Asset Turnover Ratio (%) 1.020.781.591.011.27
Current Ratio (X) 5.142.422.441.751.40
Quick Ratio (X) 3.951.501.921.330.99
Inventory Turnover Ratio (X) 7.033.087.483.534.18
Interest Coverage Ratio (X) 17.1914.3422.2517.0811.49
Interest Coverage Ratio (Post Tax) (X) 9.655.2211.628.175.64
Enterprise Value (Cr.) 152.60157.1697.08123.8063.32
EV / Net Operating Revenue (X) 3.965.181.583.071.34
EV / EBITDA (X) 35.7543.9311.2520.209.56
MarketCap / Net Operating Revenue (X) 4.075.211.583.111.29
Price / BV (X) 5.015.433.465.232.85
Price / Net Operating Revenue (X) 4.075.211.583.111.29
EarningsYield 0.010.010.040.020.04

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Arvee Laboratories (India) Ltd. is a Public Limited Listed company incorporated on 27/01/2012 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24231GJ2012PLC068778 and registration number is 068778. Currently company belongs to the Industry of Chemicals - Speciality. Company's Total Operating Revenue is Rs. 38.49 Cr. and Equity Capital is Rs. 11.02 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Speciality - Others403, Entice, Nr. Jayantilal Park BRTS, Ahmedabad Gujarat 380058Contact not found
Management
NamePosition Held
Mr. Shalin Sudhakarbhai PatelManaging Director
Mr. Shalin Bharat ChokshiWhole Time Director
Mrs. Neetu Rishi JalanInd.& Non Exe.Director
Mr. Sachin Kanwarlal KansalInd.& Non Exe.Director
Ms. Shalini Hitesh JalanInd.& Non Exe.Director

FAQ

What is the intrinsic value of Arvee Laboratories (India) Ltd and is it undervalued?

As of 14 April 2026, Arvee Laboratories (India) Ltd's intrinsic value is ₹48.57, which is 66.27% lower than the current market price of ₹144.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (6.79 %), book value (₹28.5), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Arvee Laboratories (India) Ltd?

Arvee Laboratories (India) Ltd is trading at ₹144.00 as of 14 April 2026, with a FY2026-2027 high of ₹291 and low of ₹129. The stock is currently near its 52-week low. Market cap stands at ₹159 Cr..

How does Arvee Laboratories (India) Ltd's P/E ratio compare to its industry?

Arvee Laboratories (India) Ltd has a P/E ratio of 76.3, which is above the industry average of 64.87. The premium over industry average may reflect growth expectations or speculative interest.

Is Arvee Laboratories (India) Ltd financially healthy?

Key indicators for Arvee Laboratories (India) Ltd: ROCE of 9.58 % is on the lower side compared to the industry average of 12.98%; ROE of 6.79 % is below ideal levels (industry average: 25.40%). Dividend yield is 0.00 %.

Is Arvee Laboratories (India) Ltd profitable and how is the profit trend?

Arvee Laboratories (India) Ltd reported a net profit of ₹2 Cr in Mar 2025 on revenue of ₹38 Cr. Compared to ₹3 Cr in Mar 2022, the net profit shows a declining trend.

Does Arvee Laboratories (India) Ltd pay dividends?

Arvee Laboratories (India) Ltd has a dividend yield of 0.00 % at the current price of ₹144.00. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Arvee Laboratories (India) Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports